Glutathione Skin Whitening: Permanent or Temporary
GBD 2019 Diseases and Injuries Collaborators
Potential Causes of Allodynia Allodynia is associated with several neurological and metabolic conditions, including: Peripheral Neuropathy (due to diabetes, chemotherapy, or autoimmune disorders) Fibromyalgia (central pain sensitisation disorder) Migraine Disorders (involving trigeminal nerve hypersensitivity) Neuroinflammation and Immune Dysregulation (as seen in post-viral syndromes) Medication Side Effects, including possible links to GLP-1 receptor agonists Mechanisms: How GLP-1 Medications May Contribute to Allodynia GLP-1 receptor agonists (e.g., Mounjaro, Wegovy) are widely used for weight loss and glycemic control due to their role in glucose-dependent insulin secretion and appetite suppression
Future studies are expected to elucidate the safety and efficacy of 5-amino-1MQ, identifying specific populations that may benefit or experience adverse effects
If left untreated, the deficiency can cause severe neurologic problems and blood diseases
The other drug class that is often used to treat this is RAS inhibitors which have also shown about a 40% non-responder rate
